A previous study has revealed that G protein alpha inhibitory subunit 1 (Gαi1) may act as a target for treating RCC, due to inhibition of Gαi1 which could promote cell apoptosis by downregulating AKT/mTOR and ERK/MAPK pathways [30]. The gene discussed is MTOR; the disease is renal cell carcinoma.